N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]methyl]dodecyl Ester orlistat 96829-58-2 Tetrahydrolipstatin Xenical Orlipastat Alli (-)-Tetrahydrolipstatin THLP tetrahydrolipastatin Ro 18-0647/002 orlistatum Ro-18-0647/002 (2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl (2S)-2-formamido-4-methylpentanoate DTXSID8023395 [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate 95M8R751W8 NSC-758881 Ro-180647002 Ro-180647-002 CHEBI:94686 DTXCID40820067 L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))- Beacita ((2S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) (2S)-2-formamido-4-methylpentanoate (2S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl (2S)-2-formamido-4-methylpentanoate RefChem:389166 A08AB01 Ro 18 0647 639-755-1 Orlipastatum [INN-Latin] Orlistat (Alli, Xenical) MFCD05662360 Orlistat (Standard) L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester Ro-18-0647 C29H53NO5 MLS002207022 N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone CHEMBL175247 Orlipastatum SMR000466339 L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester [(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate Orlistat Powder (S)-(S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)tridecan-2-yl 2-formamido-4-methylpentanoate (2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate Xenical (TN) CAS-96829-58-2 SR-01000759417 Orlistat [USAN:INN:BAN] UNII-95M8R751W8 HSDB 7556 N-formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester NCGC00095128-01 (-)-Tetrahydrolipstatin; Orlistat; Ro 18-0647/002; Tetrahydrolipstatin; Xenical; L-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester, [2S-[2alpha(R*),3beta]]- KS-1183 Lipase Inhibitor, THL ORLISTAT [HSDB] ORLISTAT [USAN] ORLISTAT [INN] ORLISTAT [JAN] ORLISTAT [MI] (-)-tetrahydrolipostatin ORLISTAT [VANDF] R-212 ORLISTAT [MART.] ORLISTAT [USP-RS] ORLISTAT [WHO-DD] Orlistat (JAN/USP/INN) ORLISTAT [EMA EPAR] Orlistat, >=98%, solid SCHEMBL16408 MLS000759448 MLS001423955 Orlistat - Bio-X trade mark BIDD:GT0853 ORLISTAT [ORANGE BOOK] GTPL5277 orb1310386 ORLISTAT [USP MONOGRAPH] BDBM24567 HY-B0218R AHLBNYSZXLDEJQ-FWEHEUNISA-N Tetrahydrolipstatin;Ro-18-0647 GLXC-05010 HMS2051I08 HMS3413P06 HMS3677P06 (S)-((S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-formamido-4-methylpentanoate HY-B0218 MSK10348 THL Tox21_111437 EBC-11225 HB4009 s1629 AKOS015894875 Tox21_111437_1 CCG-100851 DB01083 FO26582 NC00101 NSC 758881 Ro18-0647 NCGC00165856-01 NCGC00165856-02 NCGC00165856-03 NCGC00165856-14 NCGC00165856-15 BO164179 R212 SY078600 CS-0694775 NS00004788 O0381 SW197481-2 Ro-18-0647-002 D04028 EN300-268136 AB00639987-09 AB00639987_10 F801707 Q424163 SR-01000759417-5 SR-01000759417-7 BRD-K63343048-001-12-2 BRD-K63343048-001-13-0 Z2379810072 Orlistat, United States Pharmacopeia (USP) Reference Standard Orlistat, Pharmaceutical Secondary Standard; Certified Reference Material N-formyl-L-leucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester N-formyl-L-leucine-(S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-dodecyl ester (2S)-2-formamido-4-methylpentanoic acid [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester (S)-2-FORMYLAMINO-4-METHYL-PENTANOICACID(S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYLESTER [(2S)-1-[(2R,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2R)-2-formamido-4-methylpentanoate 104872-04-0 L-LEUCINE, N-FORMYL-, 1-((3-HEXYL-4-OXO-2-OXETANYL)METHYL)DODECYL ESTER, (2S-(2.ALPHA.(R*),3.BETA.))-
Mostrar todos os 138 sinônimos 
